STK11 mutation status is associated with decreased survival in meningiomas

ConclusionThese data identify recurrentSTK11 mutations in a subset of meningiomas. Genotyping ofSTK11 is encouraged for meningioma patients undergoing immunotherapy-based therapy.

http://link.springer.com/10.1007/s10072-020-04372-y

Source: Neurological Sciences - April 6, 2020 Category: Neurology Source Type: research